Evidence map›Paper›PMID 19780870›Full record

ArticleJournal of cellular and molecular medicine2010

Enhanced neointimal hyperplasia and carotid artery remodelling in sequestosome 1 deficient mice.

Rika Sugimoto, Eiji Warabi, Satoru Katayanagi, Satoshi Sakai, Junya Uwayama, Toru Yanagawa, Ayaka Watanabe, Harumi Harada, Kiyoshi Kitamura, Noriko Noguchi and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 26 citations in OpenAlex.

  1. Autophagy-mediatedAutophagy · 2019
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Deficiency of p62/Sequestosome 1 causes hyperphagia due to leptin resistance in the brain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  7. Article
  8. Neighbor of Brca1 gene (Nbr1) functions as a negative regulator of postnatal osteoblastic bone formation and p38 MAPK activity.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Rika SugimotoMajors of Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Eiji Warabi
Satoru Katayanagi
Satoshi Sakai
Junya Uwayama
Toru Yanagawa
Ayaka Watanabe
Harumi Harada
Kiyoshi Kitamura
Noriko Noguchi
Hiroshi Yoshida
Richard C M Siow
Giovanni E Mann
Tetsuro Ishii
University of Tsukuba · JPKing's College London · GBDoshisha University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deficiency in the signal adaptor protein sequestosome 1 (SQSTM1/A170/p62) in mice is associated with mature-onset obesity, accompanied by insulin and leptin resistance. We previously established that redox sensitive transcription factor Nrf2 up-regulates SQSTM1 expression in response to atherogenic stimuli or laminar shear stress in vascular cells, and here examine the role of SQSTM1 in neointimal hyperplasia and vascular remodelling in vivo following carotid artery ligation. Neointimal hyperplasia was markedly enhanced at ligation sites after 3 weeks in SQSTM1(-/-) compared with wild-type (WT) mice. The intimal area and stenotic ratio were, respectively, 2.1- and 1.7-fold higher in SQSTM1(-/-) mice, indicating enhanced proliferation of vascular smooth muscle cells (SMCs). When aortic SMCs were isolated from WT and SQSTM1(-/-) mice and cultured in vitro, we found that SQSTM1(-/-) SMCs proliferated more rapidly in response to foetal calf serum (FCS) and attained 2-3-fold higher cell densities compared to WT SMCs. Moreover, migration of SQSTM1(-/-) SMCs was enhanced compared to WT SMCs. Early and late phases of p38(MAPK) activation in response to FCS stimulation were also more enhanced in SQSTM1(-/-) SMCs, and inhibitors of p38 and ERK1/2 signalling pathways significantly attenuated SMC proliferation. In summary, SQSTM1(-/-) mice exhibit enhanced neointimal hyperplasia and vascular remodelling following arterial ligation in vivo. The enhanced proliferation of SQSTM1(-/-) aortic SMCs in vitro highlights a novel role for SQSTM1 in suppressing smooth muscle proliferation following vascular injury.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCarotid Artery, CommonCell MovementCell ProliferationCells, CulturedCoronary CirculationDNAEnzyme ActivationFlow CytometryHeat-Shock ProteinsHyperplasiaMiceMice, KnockoutModels, BiologicalMyocytes, Smooth MuscleAdaptor Proteins, Signal TransducingDNAHeat-Shock Proteinsp38 Mitogen-Activated Protein KinasesProtein Kinase InhibitorsSequestosome-1 ProteinSqstm1 protein, mouse

Identifiers

PMID19780870
PMCPMC3829020
OpenAlexW2002325050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.